115 related articles for article (PubMed ID: 18035696)
1. [Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype].
Stöhr R; Catto JW; Azzouzi A; Rehmann I; Feeley K; Meuth M; Hamdy F; Burger M; Hartmann A
Verh Dtsch Ges Pathol; 2005; 89():225-33. PubMed ID: 18035696
[TBL] [Abstract][Full Text] [Related]
2. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
Catto JW; Hartmann A; Stoehr R; Bolderson E; Rehman I; Rosario DJ; Hamdy FC; Meuth M
J Urol; 2006 Jun; 175(6):2323-30. PubMed ID: 16697867
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract.
Mongiat-Artus P; Miquel C; Van der Aa M; Buhard O; Hamelin R; Soliman H; Bangma C; Janin A; Teillac P; van der Kwast T; Praz F
Oncogene; 2006 Mar; 25(14):2113-8. PubMed ID: 16288216
[TBL] [Abstract][Full Text] [Related]
5. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
Walsh AM; Bailly GG; Bell DG; Norman RW; Gupta R; Zayed E; Nassar BA
Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
[TBL] [Abstract][Full Text] [Related]
9. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
10. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
Derks S; Postma C; Carvalho B; van den Bosch SM; Moerkerk PT; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
Carcinogenesis; 2008 Feb; 29(2):434-9. PubMed ID: 18048385
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
[TBL] [Abstract][Full Text] [Related]
13. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
[TBL] [Abstract][Full Text] [Related]
14. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O
BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
17. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
Mongiat-Artus P; Miquel C; van der Aa M; Buhard O; Hamelin R; Bangma C; Teillac P; van der Kwast T; Praz F
Eur Urol; 2006 Apr; 49(4):685-90. PubMed ID: 16413104
[TBL] [Abstract][Full Text] [Related]
18. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis].
Habuchi T; Kato T; Takahashi T; Ogawa O
Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205
[TBL] [Abstract][Full Text] [Related]
19. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
[TBL] [Abstract][Full Text] [Related]
20. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
